Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2025-02-03 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025
Regulatory Filings Classification · 82% confidence The document is an HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” under Chapter 19B of the Listing Rules, showing movements in authorised and issued share capital for the month ended 31 January 2025. It is a routine regulatory return required by the exchange rather than an earnings release, annual report, proxy statement or specific corporate action announcement. This fits the fallback category for miscellaneous regulatory filings (RNS).
2025-02-03 English
CHANGE OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings Classification · 76% confidence The document is an official announcement by Hongkong Chinese Limited regarding the administrative change of its Hong Kong branch share registrar and transfer office effective 1 March 2025. It is not an AGM material, financial report, management change, dividend notice, share issue, or any other specific category. It falls under general regulatory announcements. Therefore, it is classified as a Regulatory Filing (RNS).
2025-01-27 English
VOLUNTARY ANNOUNCEMENT COOPERATION BETWEEN 3SBIO INC. AND DUALITY BIOLOGICS IN RESPECT OF HER2 ADC DRUG
Regulatory Filings Classification · 86% confidence The document is a voluntary announcement by 3SBio Inc. regarding a collaboration/licensing agreement with Duality Biologics for commercialization rights of a HER2 ADC drug. It does not fit any specific category such as earnings release, M&A, financing, board changes, etc. It is an ad-hoc regulatory announcement of a business cooperation, so the most appropriate classification is the fallback category Regulatory Filings (RNS).
2025-01-13 English
INSIDE INFORMATION - RELEASE OF CHARGE OF SHARES BY CONTROLLING SHAREHOLDER
Capital/Financing Update Classification · 85% confidence The announcement is an HKEX filing disclosing that the controlling shareholder’s pledged shares have been released, referencing loan facilities and security arrangements. This pertains to a change in financing/capital structure rather than a routine board change or dividend notice. It does not announce a vote, share issuance, or management change, but updates on financing arrangements. Therefore, it is best classified under Capital/Financing Update (CAP).
2025-01-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings Classification · 86% confidence The document is a standardized HKEX FF301 Monthly Return for Equity Issuers, detailing movements in authorized share capital, issued shares, treasury shares, share options, etc., for the period ended 31 December 2024. It is a regulatory compliance filing under the Exchange Listing Rules (Chapter 19B), not an earnings announcement, investor presentation, or a full financial report. There is no specific Premium category for a periodic HKEX return, so this falls under the general ‘Regulatory Filings’ (RNS) fallback category.
2025-01-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
Regulatory Filings Classification · 85% confidence The document is a mandatory monthly return (Form FF301) filed with HKEX detailing movements in authorized and issued share capital and related confirmations. It is not an annual or interim financial report, nor an earnings release or AGM material. It serves as a routine regulatory filing under the Listing Rules rather than announcing a specific transaction. Therefore, the best fit is the fallback category “Regulatory Filings” (RNS).
2025-01-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.